Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ARTIS DEAN RICHARD Insider Profile
4 Followers
ARTIS DEAN RICHARD, EVP & CHIEF SCIENTIFIC OFFICER at Annexon Biosciences, holds 89.33K shares in Annexon Biosciences (Ticker: ANNX).
ARTIS DEAN RICHARD has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of ARTIS DEAN RICHARD's holdings
Insider Roles
EVP & CHIEF SCIENTIFIC OFFICER
Roles that ARTIS DEAN RICHARD holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by ARTIS DEAN RICHARD
ARTIS DEAN RICHARD's Trading History
List of latest transactions for each holding click on a transaction to see ARTIS DEAN RICHARD's performance on stock
You May Also Like
ARTIS DEAN RICHARD insider profile FAQ
What is the percentage of profitable transactions made by ARTIS DEAN RICHARD?
The percentage of profitable transactions made by ARTIS DEAN RICHARD is ―.
What is the average return per transaction made by ARTIS DEAN RICHARD?
The average return per transaction made by ARTIS DEAN RICHARD is ―.
What stocks does ARTIS DEAN RICHARD hold?
ARTIS DEAN RICHARD holds: ANNX stocks.
What was ARTIS DEAN RICHARD’s latest transaction?
ARTIS DEAN RICHARD latest transaction was an Uninformative Buy of ―.
What was ARTIS DEAN RICHARD's most profitable transaction?
ARTIS DEAN RICHARD’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is ARTIS DEAN RICHARD's role in Annexon Biosciences?
ARTIS DEAN RICHARD's role in Annexon Biosciences is EVP & CHIEF SCIENTIFIC OFFICER.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.